Kenya will receive funds directly from Gavi to purchase vaccines of its choice, ending a 25-year arrangement in which the global vaccine group disbursed money through multiple separate grants tied to individual vaccines.
Under the new model, each country will receive one consolidated budget for vaccine purchases.
